Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6
Welcome, Introduction & Case Presentation
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
from Ancillary Symposium 2015 on March 7, 2015 5:45 AM-8:00 AM
Current Challenges in Cholesterol Therapy and ASCVD
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
from Ancillary Symposium 2015 on March 7, 2015 5:45 AM-8:00 AM
Uncovering the Biological and Genetic Aspects of PCSK9 and the LDL Receptor
Ira Jay Goldberg, MD
New York University, New York, NY
from Ancillary Symposium 2015 on March 7, 2015 5:45 AM-8:00 AM
PCSK9 Inhibitors - Mechanism of Action, Safety, and Clinical Efficacy
Kenneth R Feingold, MD
University of California San Francisco, San Francisco, CA
from Ancillary Symposium 2015 on March 7, 2015 5:45 AM-8:00 AM
Potential Applications of PCSK9 Inhibitors in Clinical Practice
Evan A Stein, MD, PhD
Metabolic and Atherosclerosis Research Center, Cincinnati, OH
from Ancillary Symposium 2015 on March 7, 2015 5:45 AM-8:00 AM
Cases and Panel Discussion
Sergio Fazio, MD, PhD
Oregon Health and Science University, Portland, OR
Ira Jay Goldberg, MD
New York University, New York, NY
Kenneth R Feingold, MD
University of California San Francisco, San Francisco, CA
Evan A Stein, MD, PhD
Metabolic and Atherosclerosis Research Center, Cincinnati, OH
from Ancillary Symposium 2015 on March 7, 2015 5:45 AM-8:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 6 of 6